Spring From Our CEO. Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Spring 2013. From Our CEO. Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai"

Transcription

1 From Our CEO Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai Featured Story WuXi and PRA Form Joint Venture to Offer Clinical Research Services in China Platform News WuXi Receives Letter from AAALAC Commending Exemplary Animal Care WuXi Manufacturing Subsidiary STA Receives Quality CMO Award WuXi and OMT Expand Human Antibody Development and Commercial Opportunities Global Connections World-Class Scientists Lecture at WuXi WuXi Presents the 2012 Life Science and Chemistry Awards Discovery Development Biologics Medical Device Chemistry Toxicology Bioanalytical Clinical and Regulatory Genome Center Biological Reagents

2 From Our CEO 2 From Our CEO Dear valued customers, collaborative partners and friends, For twelve years, WuXi takes pride in providing high-quality R&D services to our customers in a cost-effective and efficient way. Through the support of our customers and partners, we have been able to achieve solid growth in our global business. On behalf of all WuXi employees, I want to thank you for your continued trust and confidence in WuXi. We are proud of what we accomplished for our customers in In February, we opened a chemistry facility in Wuhan to give our customers a new pricing option. In October, we began operation of a new cgmp drug-substance biologics manufacturing facility in Wuxi. We signed many new contracts in biologics, including a joint venture with MedImmune to co-develop the anti-il6 monoclonal antibody for the China market. We delivered nine small molecule preclinical drug candidates for our clients. We produced advanced intermediates for five commercial products and grew our late-stage manufacturing pipeline. The company entered into an agreement to form a joint venture with PRA to offer clinical research services in China. And we continued to invest in building new capabilities and capacities with $67.8 million in new capital assets to better serve you, our value customers. Our goal is to build an open-access technology and capability platform that will enable anyone and any company to discover and develop therapeutic products to benefit patients. Thank you very much again for helping WuXi to achieve where we are today. We will continue to strive serving you better with our integrated service platform. Ge Li, PhD Chairman and CEO

3 WuXi Forum - Gateway to China January 8, 2013 Grand Hyatt San Francisco China is the world s 3rd largest pharmaceutical market, 2nd largest economy, and 1st largest population with huge unmet medical needs. This special forum hosted by WuXi during JP Morgan Conference focused on issues relating to global health, China in particular, global strategies for discovering and developing innovative medicines, and perspectives from senior executives with China experience. Cuong Viet Do, Executive Vice President and Chief Strategy Officer at Merck, addressed audience with keynote: "China - Must Win Market for Future Survival". Panel Discussion. From left to right: Rich Soll, SVP and Head of Corporate Alliances at WuXi (moderator), Peter Mueller, EVP of Global R&D and CSO at Vertex Pharmaceuticals, Bahija Jallal, EVP of R&D at MedImmune, and Edward Hu, COO and CFO at WuXi. 180 industry executives participated in the WuXi Forum and reception.

4 Special Event 4 Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai Chinese Premier Li Keqiang visited WuXi's headquarter in Shanghai on March 28, The visit was part of the first research tour by the newly elected Chinese Premier since assuming office in March diseases prevalent in the Chinese population, and WuXi strives to become the partner-of-choice for its global collaborators to bring more innovative products to the fast-growing Chinese healthcare market. Dr. Ge Li, Chairman and Chief Executive Officer of WuXi, accompanied Premier Li on the tour of our research laboratories. "We are very excited to host Premier Li at WuXi," said Dr. Ge Li. "He always pays close attention to the healthcare industry and the well-being of Chinese people. WuXi will continue to strengthen our platform to enable more companies, organizations and entrepreneurs to discover and develop better therapeutic products for patients." Premier Li's visit highlights WuXi's leadership in China's life science industries. It also highlights the role of innovation in fostering the country's growth and improving quality of life for Chinese patients. China's strategic investment in healthcare aims to make available more effective and affordable treatments for

5 Featured Story 5 WuXi and PRA Form Joint Venture to Offer Clinical Research Services in China China's pharmaceutical market today is the third largest in the world and growing very rapidly. Biopharmaceutical companies increasingly need sophisticated clinical-trial management services to gather the highest-quality data in Chinese patients to complete Chinese and international regulatory filings as quickly and successfully as possible. Expertise in global clinical trials as well as deep local knowledge is essential to ensure success. In December 2012, WuXi announced a joint venture (JV) with PRA International, a leading global clinical contract research organization, to offer a broad platform of Phase I-IV clinical research services for the Chinese market. The joint venture will provide services that include clinical trial monitoring, project management, regulatory strategy and submissions, data management, biostatistics, drug safety reporting, and medical monitoring. The joint venture will be operated under WuXi PRA Clinical Research Co. Ltd. WuXi will contribute clinical and regulatory experience to the joint venture from its China-based clinical organization. That organization covers all regions of the country and has employees working in 16 Chinese cities, with offices in Shanghai, Beijing and Guangzhou. PRA offers the joint venture a wealth of global resources and clinical research expertise, reflected in more than 3,100 studies conducted over the last five years and contributions to 40 approved drugs in several therapeutic areas. "PRA's global experience and technical expertise and WuXi's operational experience and knowledge in China are a perfect fit. Our companies also share a culture dedicated to delivering excellent customer service, valuing employees and meeting the highest standards of quality." Colin Shannon President and CEO PRA International "We are delighted to partner with PRA to build the leading clinical-trial services operation in China. We aim to become the clinical trial service provider of choice in China with the highest quality standards and operational excellence." Dr. Ge Li Chairman and CEO WuXi AppTec Partner News: PRA Voted Best CRO in Asia PRA International, a leading Clinical Research Organization and one of WuXi s strategic partners, was voted Best CRO for the 3rd annual BioPharma Asia Industry Awards "We are deeply honored to have been voted 'Best CRO. Our recent joint venture with WuXi PharmaTech in China is just another of the many steps we have taken to further enhance our ability to provide excellent service in Asia s biopharmaceutical market, commented Kent Thoelke, PRA Executive Vice President, Scientific and Medical Affairs.

6 Platform News 6 WuXi Receives Letter from AAALAC Commending Exemplary Animal Care In March 2013, WuXi s Suzhou toxicology facility was awarded the full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC), which commended the facility for providing and maintaining an exemplary program of animal care. Accreditation from AAALAC, the organization that sets the worldwide standard for animal care and handling, reflects our continuing commitment to the highest industry and regulatory standards, and our unwavering commitment to provide our clients the highest quality services. WuXi Manufacturing Subsidiary STA Receives Quality CMO Award On March 13, 2013, Shanghai Syn-The-All Pharmaceutical Co. Ltd. ( STA ), a wholly owned subsidiary of WuXi, received a Quality Award at the CMO Leadership Awards Reception and Ceremony hosted at the DCAT Conference in Washington D.C. by Life Science Leader magazine. Winners of the awards were selected by Nice Insight, which annually surveys over 11,000 buyers of outsourced services. WuXi and OMT Expand Human Antibody Development and Commercial Opportunities In March 2013, WuXi and Open Monoclonal Technology, Inc. (OMT), an innovator in novel transgenic animals for development of human therapeutic antibodies, announced a second agreement that expands WuXi's use of OMT's OmniRat and OmniMouse technologies and strengthens the development and commercial opportunities for WuXi's Asian regional and global clients. WuXi is the first and currently the only company authorized by OMT to host OmniRat in China. This transaction advances WuXi's goal of working with skilled partners to enhance the company's technologies and capabilities to better serve its customers. The OmniRat platform has now been duplicated at WuXi's Shanghai facility, enabling WuXi to generate antibodies for customers from its own laboratories. Under the new agreement, WuXi's clients can choose to develop and commercialize products globally or regionally in China, Korea, Japan or other Asian countries. This new agreement allows WuXi to further expand its service offerings with the OmniRat and OmniMouse platforms," said Edward Hu, Chief Operating Officer and Chief Financial Officer of WuXi. "WuXi is proud of the confidence OMT has shown in the quality of WuXi's antibody research capabilities and intellectual property protection practices in authorizing WuXi to host the OmniRat and OmniMouse platforms in our laboratories."

7 Global Connections 7 World-Class Scientists Lecture at WuXi Chi-Huey Wong, PhD President, Academia Sinica Professor, Scripps Research Institute Richard Ulevitch, PhD Venture Partner, 5AM Ventures Professor, Scripps Research Institute Raymond Stevens, PhD Professor, Scripps Research Institute Lecture Title Advances in Glycoscience: Interplay of Chemistry and Biology Dec 6, 2012 Lecture Title Systems Guided Forward Genetics as the Way to Identify Novel Drug Targets Jan 18, 2013 Lecture Title Structure, Function, and Drug Discovery of the GPCR Superfamily Mar 5, 2013 WuXi Presents the 2012 Life Science and Chemistry Awards WuXi announced the winners of its sixth annual Life Science and Chemistry Awards at a ceremony held on January 20, Eighteen highly accomplished young scholars were honored after a rigorous and transparent selection process that began in May The WuXi PharmaTech Life Science and Chemistry Awards originated in 2007 as the first nationwide scientific award in China established by a life science enterprise. The awards aim to foster early innovation and encourage pursuit of excellence in life science research. During the six years since its inception, 95 scholars from more than 30 premier Chinese universities and research institutes have received awards, three of whom were later elected to the Chinese Academy of Sciences or the Chinese Academy of Engineering.

8 We are determined to serve you better! Shanghai R&D Headquarter Clinical / Regulatory CHINA Jinshan Small Molecule Manufacturing Wuhan Chemistry Wuxi Biologics Manufacturing Suzhou Toxicology Suzhou Biologics Reagents Tianjin Chemistry US St Paul, MN Medical Device Testing Lansdale, PA Program Management Edison, NJ Program Management Philadelphia, PA Biologics Testing & Manu. Atlanta, GA Biologics Testing & Manu. San Diego, CA Marketing & Distribution CONTACT by WuXi AppTec. All rights reserved.

WuXi PharmaTech Announces Second-Quarter 2014 Results

WuXi PharmaTech Announces Second-Quarter 2014 Results WuXi PharmaTech Announces Second-Quarter 2014 Results SHANGHAI, August 13, 2014 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving

More information

2015 / 2016 Awards Criteria and Submission Information

2015 / 2016 Awards Criteria and Submission Information 9 th Annual ViE Awards 2015 / 2016 Awards Criteria and Submission Information In association with: Dear colleague, The Vaccine Industry Excellence (ViE) Awards have been created to honor and generate recognition

More information

SERVICES FOR. Devices and Combination Products

SERVICES FOR. Devices and Combination Products SERVICES FOR Devices and Combination Products How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta,

More information

exactly. The need for efficiency in developing effective new therapeutics has never been greater.

exactly. The need for efficiency in developing effective new therapeutics has never been greater. exactly. The need for efficiency in developing effective new therapeutics has never been greater. As demands on the global healthcare system increase and treating disease becomes more complex, the research,

More information

Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd.

Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd. Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd. Roche recognizes changes in China Strong economic development

More information

Transforming Succession Planning, Leadership Development, and New-Employee Selection

Transforming Succession Planning, Leadership Development, and New-Employee Selection Transforming Succession Planning, Leadership Development, and New-Employee Selection WuXi AppTec partners with Haiwen United for dramatic improvements in human resources programs and employee training

More information

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement FOR IMMEDIATE RELEASE Ref 05AFF05 Contacts for Affitech: Contacts for XOMA Affitech (Norway): Investor Inquiries Dr. Martin Welschof Ellen M Martin Chief Executive Officer Kureczka/Martin Associates Phone:

More information

APAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015

APAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015 APAC CRO Market A deep dive into the trends transforming APAC CRO industry June 2015 Table of Contents Section Slide Numbers Executive Summary 10 Key Findings 11 Total CRO Market Size By Stages of Clinical

More information

OPKO Health to Acquire Bio-Reference Laboratories

OPKO Health to Acquire Bio-Reference Laboratories OPKO Health to Acquire Bio-Reference Laboratories - Complementary in-depth expertise in diagnostics business with state of the art experience in use of genomic data for personalized therapy - Acquisition

More information

Post-Doctoral Pharmaceutical Industry Fellowships. Two-Year Clinical Development Program Two-Year Clinical Safety Program

Post-Doctoral Pharmaceutical Industry Fellowships. Two-Year Clinical Development Program Two-Year Clinical Safety Program Post-Doctoral Pharmaceutical Industry Fellowships Two-Year Clinical Development Program Two-Year Clinical Safety Program Today, we innovate by creating new medicines, as well as new methods of drug discovery

More information

Key Findings. Use this report to... The Top 10 Contract Research Organizations

Key Findings. Use this report to... The Top 10 Contract Research Organizations Key Findings The global CRO industry valued $18bn in 2008, an increase of 14% over 2007. The CRO market will grow at an annual rate of 14% over the 2009 13 period. Quintiles leads the global CRO market

More information

SciFinder. Essential Content. Proven Results. Are You Ready for the Web? Österreichischer Bibliothekartag Innsbruck 2011

SciFinder. Essential Content. Proven Results. Are You Ready for the Web? Österreichischer Bibliothekartag Innsbruck 2011 SciFinder Essential Content. Proven Results. Are You Ready for the Web? Österreichischer Bibliothekartag Innsbruck 2011 What is SciFinder? Simply put SciFinder is the first choice for chemists and related

More information

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge

More information

Pharmaceutical Sciences

Pharmaceutical Sciences Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aapspharmaceutica.com/students How do I know if a career in the pharmaceutical sciences

More information

Medicines for Neglected Diseases Workshop. Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia

Medicines for Neglected Diseases Workshop. Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia Medicines for Neglected Diseases Workshop Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia September 11, 2010 Poverty, Many People Poor health conditions High Morbidity

More information

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to

More information

Presented at: Jefferies 2015 Global Healthcare Conference

Presented at: Jefferies 2015 Global Healthcare Conference Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution

More information

JOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1

JOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 JOHN REID PhD, MBA (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 PROFILE Senior-level business development and licensing executive with a well-honed ability to translate scientific

More information

PharmD Postdoctoral Fellowship Program

PharmD Postdoctoral Fellowship Program Novartis Institutes for Biomedical Research and Massachusetts College of Pharmacy and Health Sciences, Worcester/Manchester PharmD Postdoctoral Fellowship Program Introduction Fellowship training in the

More information

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right

More information

Biometrics: Clinical Trials and Beyond

Biometrics: Clinical Trials and Beyond Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane

More information

ACC San Diego Chapter

ACC San Diego Chapter ACC San Diego Chapter Biomedical and Technology Collaborations with Chinese Companies: Legal and Cultural Challenges October 2012 DLA Piper Overview Our Firm 4,200 lawyers in 77 offices and 33 countries

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com. April 17, 2015.

15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com. April 17, 2015. 15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com April 17, 2015 Dear Shareholder, We are experiencing exciting times at HemaCare. Over the course of

More information

Executive Search Announcement

Executive Search Announcement Executive Search Announcement i n v i t e s a p p l i c a t i o n s a n d n o m i n a t i o n s f o r Assistant Dean for Research for the School of Nursing and School of Health Professions The University

More information

-more- For immediate release: November 1, 2012

-more- For immediate release: November 1, 2012 For immediate release: November 1, 2012 Portola Pharmaceuticals Media Contact: Paul Laland, WCG for Portola plaland@wcgworld.com 415-946-1071 Bristol-Myers Squibb Media Contact: Laura Hortas, 609-252-4587

More information

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA PharmaSUG 2014 Paper CP07 Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA ABSTRACT In the biopharmaceutical

More information

Drug Development Models in China and the Impact on Multinational Pharmaceutical Companies

Drug Development Models in China and the Impact on Multinational Pharmaceutical Companies Drug Development Models in China and the Impact on Multinational Pharmaceutical Companies By Ling Su, Ph.D. China represents a huge potential opportunity for the pharmaceutical industry in both commercial

More information

Bioethics Education in Professional Science Master s Programs at California State University Channel Islands

Bioethics Education in Professional Science Master s Programs at California State University Channel Islands ETHICS AND THE PSM Bioethics Education in Professional Science Master s Programs at California State University Channel Islands Ching-Hua Wang, M.D., Ph.D., Director of MS Biotechnology and Bioinformatics

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

Aiming for International Leading University by excellence in

Aiming for International Leading University by excellence in Aiming for International Leading University by excellence in 1. Education 2. Research 3. Contribution to Society 4. Campus Environment 5. Organization / Management Research Foster Post-Doctoral Fellows

More information

Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search

Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search Spring 2013 About NEOMED Northeast Ohio Medical University (NEOMED) www.neomed.edu is a dynamic free-standing community-based,

More information

Symposium on Innovation in Healthcare Technology and Delivery

Symposium on Innovation in Healthcare Technology and Delivery Symposium on Innovation in Healthcare Technology and Delivery March 10, 2014, 1-6pm, Stevens Babbio Center, Hoboken NJ 1:00-1:30 Opening Remarks Nariman Farvardin, PhD, Professor and University President,

More information

MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME

MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME FOR IMMEDIATE RELEASE MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME - $185 Million Collaboration to Determine All Human Protein Interactions And Decipher Biochemical Pathways

More information

Dear Business Development or Corporate Alliance Director/Manager,

Dear Business Development or Corporate Alliance Director/Manager, Korea Drug Research Association(KDRA) and Korea Health Industry Development Institute(KHIDI) cordially request the potential global outsourcing partners(cros, CMOs, CSOs & Consulting Firms) having contract

More information

Acquisition of Boston Biomedical Inc. February 29, 2012 Dainippon Sumitomo Pharma Co., Ltd.

Acquisition of Boston Biomedical Inc. February 29, 2012 Dainippon Sumitomo Pharma Co., Ltd. Acquisition of Boston Biomedical Inc. February 29, 2012 Dainippon Sumitomo Pharma Co., Ltd. Oncology Strategy and Acquisition Significance 1 Commitment to Oncology Entering the Oncology Area Globally External

More information

WXPRESS. December 2009. An Integrated R&D Service Company

WXPRESS. December 2009. An Integrated R&D Service Company WXPRESS December 2009 Shanghai Suzhou Tianjin Philadelphia St. Paul An Integrated R&D Service Company Atlanta In this edition: Holiday Greetings from Dr. Ge Li, Chairman and CEO, to Our Customers, Partners,

More information

The Medical Communications Agency

The Medical Communications Agency The Medical Communications Agency Paul Hatton E U R O P E U N I T E D S T A T E S A S I A P A C I F I C Objectives What do medical communications agencies do? What might a career in medical communications

More information

Biosimilars 20/20. The Future is at Hand

Biosimilars 20/20. The Future is at Hand Welcome to Biosimilars 20/20, presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ). Please note that this is a preliminary agenda that is subject

More information

Curriculum Vitae. Education Nanjing University, International Business School, Nanjing, P. R.China Bachelor of Arts in Economics, July 1994

Curriculum Vitae. Education Nanjing University, International Business School, Nanjing, P. R.China Bachelor of Arts in Economics, July 1994 Curriculum Vitae Zhining Hu Office Contact Information Department of Economics Gettysburg College Gettysburg, PA 17325 Office phone number: 717-337-6676 E-mail address: zhu@gettysburg.edu Education Nanjing

More information

Regional Strategies 82/90

Regional Strategies 82/90 Regional Strategies 82/90 Global Operations NTT Com Group has subsidiaries and offices in 85 cities in 30 countries/regions except Japan, which connect networks to more than 150 countries around the world.

More information

A vaccine for rheumatoid arthritis

A vaccine for rheumatoid arthritis A vaccine for rheumatoid arthritis Professor Ranjeny Thomas Founder and Director of Dendright Pty Limited Head, Autoimmunity Division, Diamantina Institute, The University of Queensland About Dendright

More information

Groundbreaking Collaborative Clinical Trial Launched

Groundbreaking Collaborative Clinical Trial Launched Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)

More information

Industry Insight - Indian Biopharma

Industry Insight - Indian Biopharma Brochure More information from http://www.researchandmarkets.com/reports/2043221/ Industry Insight - Indian Biopharma Description: Biopharmaceuticals are complex macromolecules (Large molecules) created

More information

Join our scientific talent community

Join our scientific talent community Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into

More information

Company Presentation

Company Presentation Company Presentation DISCLAIMER This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and asset situation of amp biosimilars

More information

We use Reaxys intensively for hit identification, hit-to-lead and lead optimization.

We use Reaxys intensively for hit identification, hit-to-lead and lead optimization. CASE STUDY Dr. Fabio C. Tucci, COO of Epigen Biosciences We use Reaxys intensively for hit identification, hit-to-lead and lead optimization. CREATING NEW ASSETS Epigen Biosciences is a start-up pharmaceutical

More information

MBS: Webinar. Please note: Voice is over the phone. Please use the call in number on the left panel.

MBS: Webinar. Please note: Voice is over the phone. Please use the call in number on the left panel. MBS: Webinar Please note: Voice is over the phone. Please use the call in number on the left panel. About Rutgers State University of New Jersey: Rutgers is the sole university in the United States that

More information

The Top 10 Contract Research Organizations

The Top 10 Contract Research Organizations OUTSOURCING The Top 10 Contract Research Organizations Positioning, performance and SWOT analyses Table of Contents Copyright 2009 Business Insights Ltd This Management Report is published by Business

More information

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before

More information

USF School of Management China Business Studies Initiative presents 旧 金 山 大 学 商 学 院 中 国 企 业 管 理 研 究 所 举 办

USF School of Management China Business Studies Initiative presents 旧 金 山 大 学 商 学 院 中 国 企 业 管 理 研 究 所 举 办 USF School of Management China Business Studies Initiative presents 旧 金 山 大 学 商 学 院 中 国 企 业 管 理 研 究 所 举 办 CBSI Forum China s New Investment Strategy: A Reality Check CBSI 论 坛 中 国 新 投 资 策 略 解 读 Sponsored

More information

Global Clinical Trial Supply & Logistics Roundtable

Global Clinical Trial Supply & Logistics Roundtable Global Clinical Trial Supply & Logistics Roundtable Examining Best Practices, Skills & Tools to Gain Competitive Edge in Clinical Trials Part One www.coldchainiq.com Globalization of Clinical Trials The

More information

HONG ZHU (SUSAN) EMPLOYMENT EDUCATION RESEARCH HONORS & AWARDS the best paper award & the best paper award JOURNAL PUBLICATIONS

HONG ZHU (SUSAN) EMPLOYMENT EDUCATION RESEARCH HONORS & AWARDS the best paper award & the best paper award JOURNAL PUBLICATIONS HONG ZHU (SUSAN) Assistant Professor, HSBC Business School, Peking University University Town, NanShan District, Shenzhen, 518055, China Phone: 86-755-2603-3781, Email: zhuhong@phbs.pku.edu.cn EMPLOYMENT

More information

Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se

Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in

More information

Gather expertise from their campus and communities to better understand the causes of and potential solutions to a complex issue.

Gather expertise from their campus and communities to better understand the causes of and potential solutions to a complex issue. Dear students VISIT US ON FACEBOOK We all hope now you have had the chance to deal with the many issues from super storm Sandy. We have been impressed with your stories of perseverance and your spirit

More information

2009 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative

2009 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative of clients 321 N. Clark Street, Suite 2800, Chicago, IL 60654 312.832.4500 Life

More information

The Future of R&D Outsourcing

The Future of R&D Outsourcing OUTSOURCING The Future of R&D Outsourcing Investigating development hurdles, key challenges & strategies to optimize CRO relationships By Alison Sahoo Alison Sahoo Alison Sahoo is a pharmaceutical industry

More information

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM 2015. Alliance. Innovation PRELIMINARY. Management

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM 2015. Alliance. Innovation PRELIMINARY. Management OCTOBER 5-6, 2015 PARIS, FRANCE 6 th EDITION THE LEADING PARTNERING MEETING IN OPEN INNOVATION FOR LIFE SCIENCES CONFERENCES EXHIBITION HALL ONE-ON-ONE PARTNERING MEETINGS NETWORKING Open PRELIMINARY PROGRAM

More information

Dr. Jing'an Tang. Department of Management. John F. Welch College of Business. Sacred Heart University

Dr. Jing'an Tang. Department of Management. John F. Welch College of Business. Sacred Heart University Dr. Jing'an Tang Department of Management John F. Welch College of Business Sacred Heart University EDUCATION 2007. Ph D, University of Western Ontario, Richard Ivey School of Business. Major: Strategy

More information

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization San Oakland San Jose Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in San The San Bay area is in many

More information

UK- India Science Bridge: BioPharm 2020

UK- India Science Bridge: BioPharm 2020 DST INDIA - RESEARCH COUNCILS UK UK- India Science Bridge: BioPharm 2020 Entrepreneurial Opportunities for Indian and UK Scientists in the Pharmaceutical and Biotechnology Industries UK-India Impact Symposium

More information

Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia

Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia Company Selects The Navy Yard as Site for U.S. Headquarters and Base for Clinical and Manufacturing Operations PHILADELPHIA, Pa and

More information

SYLLABUS. Drug development in a New Era: NYU GSAS, MSc, Sackler, SOM 2012

SYLLABUS. Drug development in a New Era: NYU GSAS, MSc, Sackler, SOM 2012 Drug development in a New Era: NYU GSAS, MSc, Sackler, SOM 2012 Course Description: Bringing a new chemical entity, drug, or device to the consumer market is a necessary but intricate, expensive, complicated,

More information

AMCF. Association of Management Consulting Firms. As the leader of a large consulting firm, I welcome the

AMCF. Association of Management Consulting Firms. As the leader of a large consulting firm, I welcome the AMCF Association of Management Consulting Firms As the leader of a large consulting firm, I welcome the opportunity to get together A and learn from the experience of leaders from other global firms. Only

More information

Pharmaceutical Industry: Research and Development

Pharmaceutical Industry: Research and Development Pharmaceutical Industry: Research and Development Background Pharmacists in industry are employed in a variety of positions. Although practice titles, descriptions, and prerequisites differ by company,

More information

Daiichi Sankyo to Acquire Ambit Biosciences

Daiichi Sankyo to Acquire Ambit Biosciences For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please

More information

PRODUCT RESEARCH & DEVELOPMENT PROCESS

PRODUCT RESEARCH & DEVELOPMENT PROCESS 0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PHARMATRAIN CENTRE OF EXCELLENCE INTRODUCTORY MODULE: PRODUCT RESEARCH & DEVELOPMENT PROCESS Aveiro

More information

What Lies Ahead? Trends to Watch: Health Care Product Development in North America

What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the

More information

BIOCLINICA, INC. TO DEMONSTRATE TECHNOLOGY-ENHANCED CAPABILITIES AT UPCOMING GLOBAL INDUSTRY EVENTS

BIOCLINICA, INC. TO DEMONSTRATE TECHNOLOGY-ENHANCED CAPABILITIES AT UPCOMING GLOBAL INDUSTRY EVENTS Company Contact - Jim Dorsey BioClinica, Inc. 267-757-3040 Trade Media Morgan Dub Karpo Diccicco Battista Communications 484-342-3600 FOR IMMEDIATE RELEASE BIOCLINICA, INC. TO DEMONSTRATE TECHNOLOGY-ENHANCED

More information

HUDSON SALARY GUIDES 2015

HUDSON SALARY GUIDES 2015 Singapore HUDSON SALARY GUIDES 2015 about this publication This Salary Guide is a compilation of salary and market information provided by Hudson consultants, clients, candidates and other sources across

More information

Issues. Does the academe have as a goal or an obligation, the development of its discoveries for human benefit?

Issues. Does the academe have as a goal or an obligation, the development of its discoveries for human benefit? ELLEN PURÉ, Ph.D. Issues Does the academe have as a goal or an obligation, the development of its discoveries for human benefit? Can the academic review process support individual career development in

More information

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS

More information

The majority of pharmaceutical companies in

The majority of pharmaceutical companies in Pharmaceutical Infrastructure and Industry Professor Che-Ming Teng, Ph.D. National Taiwan University College of Medicine, Taipei, Taiwan The majority of pharmaceutical companies in Taiwan are devoted to

More information

The fifth annual gathering of c-level executives from the most progressive hospitals

The fifth annual gathering of c-level executives from the most progressive hospitals Executive Summary Produced by Lincoln Healthcare Group About Hospital 100 Hospital 100 Leadership & Strategy Conference October 19 to 21, 2015 The Ritz-Carlton Key Biscayne, FL www.hospital100.com Hospital

More information

The Commercialization of Technology Concepts into Medical Products

The Commercialization of Technology Concepts into Medical Products The Commercialization of Technology Concepts into Medical Products Kevin J. Scanlon, Ph.D. New Zealand 2006 International BioScience Overview Pharmaceutical Industry Biotechnology Startups Investment Community

More information

THE VIRAL HEPATITIS CONGRESS 2015. 10 12 September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme

THE VIRAL HEPATITIS CONGRESS 2015. 10 12 September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme THE VIRAL HEPATITIS CONGRESS THE VIRAL HEPATITIS CONGRESS 2015 10 12 September 2015, Kap Europa, Frankfurt, Germany Scientific Programme PRE-CONGRESS WORKSHOP SPONSOR ACHILLION Achillion is seeking to

More information

SPEAKER BIOGRAPHICAL INFORMATION

SPEAKER BIOGRAPHICAL INFORMATION SPEAKER BIOGRAPHICAL INFORMATION Madeleine R. Valera MD, MScIH (Heidelberg) Dr. Valera is a senior health care service professional with over 20 years of professional expertise in Health Financing and

More information

Master of Science in Vision Science and Investigative Ophthalmology MVSIO

Master of Science in Vision Science and Investigative Ophthalmology MVSIO Master of Science in Vision Science and Investigative Ophthalmology MVSIO Global Leadership in Eye Care, Vision Research and Ophthalmology Education Bascom Palmer Eye Institute is pleased to introduce

More information

Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced

Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced September 27, 2013 ONO PHARMACEUTICAL CO., LTD. Corporate Communications Phone: +81-6-6263-5670 Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced

More information

Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results

Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results FOR IMMEDIATE RELEASE Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results Holon, ISRAEL February 9, 2016 Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today reported

More information

In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts.

In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts. Brochure More information from http://www.researchandmarkets.com/reports/1882193/ Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising

More information

MD/PhD MISSION OBJECTIVES GOALS

MD/PhD MISSION OBJECTIVES GOALS MD/PhD MISSION OBJECTIVES GOALS Mission & Objectives Overarching Objective: Train physician-scientists to be an integral component of the healthcare system, now and into the future. Expectations for Graduates:

More information

Future In Life Sciences

Future In Life Sciences Future In Life Sciences Event Series Sponsorship Overview About the Partnership Propel Careers, MassBio, and the MassBioEd joined together in 2011 to organize a series of networking and panel events focused

More information

Goizueta Healthcare Forum 2011 Leadership in Healthcare Forum February 10 th - 11 th, 2011

Goizueta Healthcare Forum 2011 Leadership in Healthcare Forum February 10 th - 11 th, 2011 Goizueta Healthcare Forum 2011 Leadership in Healthcare Forum February 10 th - 11 th, 2011 Schedule of Events February 10 th 6:30-7:15pm: Opening Address: Scott Lloyd, Co-Founder and President of Extrakare,

More information

Phoenix Healthcare Group Co. Ltd 鳳 凰 醫 療 集 團 有 限 公 司

Phoenix Healthcare Group Co. Ltd 鳳 凰 醫 療 集 團 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Profile of Biomedical Research and Biotechnology Commercialization. Washington-Baltimore Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. Washington-Baltimore Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization Washington-Baltimore Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Washington-Baltimore The Washington,

More information

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis Salary Survey 2014 Domestic, International Salary Survey and Country Cost Analysis Disclaimer: This salary guides contained herewith have been constructed to represent average salaries across a range of

More information

THE PHILIPPINE AMERICAN LIFE AND GENERAL INSURANCE COMPANY 3/F PHILAMLIFE BLDG., UN AVENUE, ERMITA, MANILA TEL. NO: 528-5029 PHILAMLIFE@AIA.

THE PHILIPPINE AMERICAN LIFE AND GENERAL INSURANCE COMPANY 3/F PHILAMLIFE BLDG., UN AVENUE, ERMITA, MANILA TEL. NO: 528-5029 PHILAMLIFE@AIA. THE PHILIPPINE AMERICAN LIFE AND GENERAL INSURANCE COMPANY 3/F PHILAMLIFE BLDG., UN AVENUE, ERMITA, MANILA TEL. NO: 528-5029 PHILAMLIFE@AIA.COM Media Release Contacts : CJ Malibiran Tel. No. 528-5029 Philam

More information

VA Names Members of National Academic Affiliations Council Panel to Help Guide Improvements in Academic Partnerships

VA Names Members of National Academic Affiliations Council Panel to Help Guide Improvements in Academic Partnerships FOR IMMEDIATE RELEASE November 14, 2011 VA Names Members of National Academic Affiliations Council Panel to Help Guide Improvements in Academic Partnerships WASHINGTON A newly formed Veterans Affairs (VA)

More information

Master of Science in BIOINFORMATICS. > information. > insight. > innovation

Master of Science in BIOINFORMATICS. > information. > insight. > innovation Master of Science in BIOINFORMATICS > information > insight > innovation The Program Master of Science in Bioinformatics The College of Science at Northeastern University is committed to delivering cutting-edge

More information

School of Medicine. January 15, 2015. a joint venture. University Health Network

School of Medicine. January 15, 2015. a joint venture. University Health Network School of Medicine January 15, 2015 a joint venture University Health Network Nancy Radwin Dan Kalmanson HackensackUMC Seton Hall University 551-996-3765 973-378-9856 NRadwin@HackensackUMC.org dan.kalmanson@shu.edu

More information

From Research Services and Process Development to GMP Manufacturing

From Research Services and Process Development to GMP Manufacturing From Research Services and Process Development to GMP Manufacturing P a r ag o n B i o s e r v i c e s, I n c. A contract research and GMP manufacturing organization (CMO) with a focus on the development

More information

Building innovative drug discovery alliances. Profitable. Growth Go

Building innovative drug discovery alliances. Profitable. Growth Go Building innovative drug discovery alliances Innovation n & Profitable Growth Go Evotec AG, H1 Presentation, 8 th August 2012 Forward-looking statements Information set forth in this presentation contains

More information

Background: Pathways for the Master s Degree (Thesis and Non Thesis)

Background: Pathways for the Master s Degree (Thesis and Non Thesis) Differences between the Non Thesis (Project) and Thesis Options for the M.S. in Pharmacy with an emphasis in BioPharma Regulatory Affairs Offered by the University of Georgia College of Pharmacy Background:

More information

Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences

Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences It s not information overload, it s filter failure. Clay Shirky Life Sciences organizations face the challenge

More information

novo nordisk Partnering for innovation IN PROTEIN-BASED THERAPEUTICS AND TECHNOLOGIES Protein Technologies Diabetes Protein Delivery Devices

novo nordisk Partnering for innovation IN PROTEIN-BASED THERAPEUTICS AND TECHNOLOGIES Protein Technologies Diabetes Protein Delivery Devices novo nordisk Partnering for innovation IN PROTEIN-BASED THERAPEUTICS AND TECHNOLOGIES Juan Jenny Li works as a chemistry professional at Novo Nordisk s research centre in Beijing Diabetes Protein Technologies

More information

Strategy Planning Management Execution Analysis

Strategy Planning Management Execution Analysis Leading the way Strategy Planning Execution Analysis 1 Excellence in Delivery ICON is a division of ICON plc. It specializes in the planning management, execution, and analysis of Phase IIb IV clinical

More information

TERM SHEET EXAMPLE. 1 P age

TERM SHEET EXAMPLE. 1 P age 1 P age TERM SHEET EXAMPLE BIOTECHCO Overview & Business Strategy BIOTECHCO (the licensor), located in North Dakota, has a proprietary technology called ZIP that can generate fully human antibodies with

More information

Brand Quality with Asian Advantages

Brand Quality with Asian Advantages Brand Quality with Asian Advantages ScinoPharm Taiwan, Ltd. No.1, Nan-Ke 8th Road, Tainan Science Park, Shan-Hua, Tainan, 74144, Taiwan TEL : 886-6-505-2888 FAX : 886-6-505-2898 Email Contact : mkt@scinopharm.com

More information

Search for Executive Director. Bethesda, Maryland

Search for Executive Director. Bethesda, Maryland Search for Bethesda, Maryland Executive Summary The Council of the American Society for Cell Biology (ASCB) welcomes applications and nominations for its next. Founded in 1960, ASCB is the primary voice

More information